Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation

Journal of Hypertension

Volumn 22, Issue 3, 2004, Pages 511-517

  Lemogoum, Daniel ^a   Flores, Gabriella ^a   Van Den Abeele, Wouter ^b   Ciarka, Agnieszka ^c   Leeman, Marc ^a   Degaute, Jean Paul ^a   Van De Borne, Philippe De ^a   Van Bortel, Luc ^b  

^a ERASME HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Augmentation index; Beta adrenergic stimulation; Pulse pressure; Pulse wave velocity; Validity

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; ISOPRENALINE; PLACEBO;

ADULT; AGING; AORTA AUGMENTATION INDEX; ARTERY DISEASE; ARTERY STIFFNESS; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR PARAMETERS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG INFUSION; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TONOMETRY; VALIDATION PROCESS;

EID: 1642297408     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200403000-00013     Document Type: Article

References (34)

1. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992; 327:998-1008.
2. O'Rourke MF. Mechanical principles in arterial disease. Hypertension 1995; 26:2-9.
3. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103:987-992.
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99:2434-2439.
5. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-41.
6. Bramwell JC, Hill AV. Velocity of transmission of the pulse wave. Lancet 1922; i:891-892.
7. Cameron JD, McGrath BP, Dart AM. Use of radial applanation tonometry and a generalized transfer function to determine aortic augmentation in subjects with treated hypertension. J Am Coll Cardiol 1998; 32:1214-1220.
8. Wilkinson IB, MacCallum H, Rooijmans DF, Murray GD, Cockcroft JR, McKnight JA, et al. Increased augmentation index and systolic stress in type1 diabetes mellitus. QJM 2000; 93:441-448.
9. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002; 39:1005-1011.
10. Millar JA, Lever AF. Burke versus pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999; 17:1065-1072.
11. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimeteere P, et al. Pulse pressure: a predictor of long-term cardiovascular mortality in French male population. Hypertension 1997; 30:1410-1415.
12. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 1989; 80:1652-1659.
13. Yasmin Brown MJ. Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM 1999; 92:595-600.
14. O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens 1993; 11:327-337.
15. Nichols WW, O'Rourke MF (eds). McDonald's blood flow in arteries. 4th edn. London: Edward Arnold; 1998, pp. 170-222, 284-315, 347-395.
16. Gatzka DC, Cameron JD, Dart AM, Berry KL, Kingwell BA, Dewar EM, et al. Correction of carotid augmentation index for heart rate in elderly essential hypertensives. Am J Hypertens 2001; 14:573-577.
17. Bortel LM Van, Hoeks AP, Kool MJ, Struijker Boudier HA. Introduction to large artery properties as a target for risk reduction by antihypertensive therapy. J Hypertens 1992; 10:S123-S126.
18. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR, Philipp T, Schafers RF. Augmentation index is associated with cardiovascular risk. J Hypertens 2002; 20:2407-2414.
19. Millar JA, Lever AF. Implications of pulse pressure as a predictor of cardiac risk in patients with hypertension. Hypertension 2000; 36:907-911.
20. Zakopoulos NA, Lekakis JP, Papamichael CM, Toumanidis ST, Kanakakis JE, Kostandonis D, et al. Pulse pressure in normotensives: a marker of cardiovascular disease. Am J Hypertens 2001; 14:195-199.
21. Safar ME, Toto-Moukouo JJ, Bouthier JA, Asmar RE, Levenson JA, Simon AC, et al. Arterial dynamics, cardiac hypertrophy and antihypertensive treatment. Circulation 1987; 75:I156-I161.
22. Saba, Roman MJ, Pini R, Spitzer M, Ganau A, Devereux RB. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22:1873-1880.
23. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16:2079-2084.
24. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Circulation 1997; 95:1827-1836.
25. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens 1996; 14:147-157.
26. Asmar R. Pulse wave velocity: principles and measurement. In: Asmar R (editor): Arterial stiffness and pulse wave velocity. Clinical applications. Amsterdam: Elsevier Science; 1999, pp. 37-55.
27. Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001; 38:1461-1466.
28. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse wave velocity in healthy men. Hypertension 2001; 37:1429-1433.
29. Smulyan H, Marchais SJ, Pannier B, Guerin AP, Safar ME, London GM. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol 1998; 31:1103-1109.
30. Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002; 15:24-30.
31. Alfie J, Waisman GD, Galarza CR, Camera MI. Contribution of stroke volume to the change in pulse pressure pattern with age. Hypertension 1999; 34:808-812.
32. Davies JI, Band MM, Pringle S, Ogston S, Struthers AD. Peripheral blood pressure measurement is as good as applanation tonometry at predicting ascending aortic blood pressure. J Hypertens 2003; 21:571-576.
33. Cloud GC, Rajkumar C, Kooner J, Cooke J, Bulpitt CJ. Estimation of central aortic pressure by SphygmoCor® requires intra-arterial peripheral pressures Clin Sci 2003; 105:219-225.
34. Bortel LM Van, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, et al. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002; 15:445-452.